StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
6859.T$3945.00+0.00%
Fair $3945.00+0.0%

6859.T

Espec Corp.

Technology / Scientific & Technical InstrumentsTokyo

$3945.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $3945.00Fund rank 33/100 · Data gapFallback financials|
SA 79/B
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $947.0M · quality 67.7/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 61/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

79/100

B

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 6859.TLocal privado en este navegador · Espec Corp.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$84.3B

P/E

14.6x

↓

EV/EBITDA

7.3x

↓

ROE

10.6%

↑

Gross Margin

35.6%

↑

Debt/Equity

0.00

↓
52-Week Range$3945
$2592$4120

TradingView lightweight chart

6859.T price, volumen y niveles de valoración

Último $3,945Periodo +298.5%
Fair value: $3,945

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+17.1%

FCF CAGR

+19.1%

FCF margin

3.4%

FCF / Net income

0.38x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $67.29B · net income $6.00B · FCF $2.26B

2022-FY → 2025-FY

Gross margin

35.6%+2.2% pts

Operating margin

11.2%+6.5% pts

Net margin

8.9%+4.4% pts

FCF margin

3.4%+0.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$67.29B$67.29B$62.13B$52.89B$41.85B
Net Income$6.00B$6.00B$4.97B$3.33B$1.91B
EBITDA$10.13B$10.13B$8.66B$6.17B$4.15B
EPS274.97274.97227.61150.3484.89
Gross Margin35.6%35.6%35.4%34.0%33.5%
Operating Margin11.2%11.2%10.6%8.3%4.7%
Net Margin8.9%8.9%8.0%6.3%4.6%
Balance Sheet
Debt/Equity0.000.000.100.010.01
Current Ratio3.313.31———
Cash Flow
Free Cash Flow$2.26B$2.26B$498.0M$947.0M$1.34B
Returns
ROE10.6%10.6%9.4%7.1%4.2%
Valuation
P/E14.6014.6013.0713.3921.65
EV/EBITDA7.267.266.205.016.84
P/B1.521.521.230.950.91
Growth & Yield
Revenue Growth8.3%8.3%17.5%26.4%—
EPS Growth20.8%20.8%51.4%77.1%—
Dividend Yield3.5%3.5%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

8.4%

razonable

EPS terminal req.

$350.05

Spread vs growth

12.4%

5Y implied EPS CAGR

9.0%

razonable

EPS terminal req.

$423.56

Spread vs growth

11.8%

10Y implied EPS CAGR

9.5%

razonable

EPS terminal req.

$682.15

Spread vs growth

11.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +53.4%

Total return

+53.4%

Start / end P/E

11.6x → 14.3x

EPS bridge

227.61 → 274.97

Residual

+5.0%

EPS growth+20.8%
Multiple rerating+24.1%
Dividend+3.5%
Residual / FX / buybacks / cross-term+5.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.